Acute Myocardial Infarction Clinical Trial
Official title:
Enhanced Feedback for Effective Cardiac Treatment (EFFECT)
Randomized cluster trial of cardiac report cards for AMI and CHF. 103 acute care Ontario
hospitals/85 hospital corporations participating, randomized to two groups: Group A Early
Feedback and Group B Delayed Feedback.
Two phases of retrospective chart review of AMI and CHF separations to assess the impact of
the public release of hospital specific performance on a set of Canadian quality indicators.
Study Overview:
The EFFECT Study is one of the largest and most comprehensive initiatives in the world to
measure and improve the quality of cardiac care. A randomized trial of cardiac care report
cards, the study's objective is to determine whether developing and publishing report cards
based on clinical data collected from patient charts leads to greater use of evidence-based
therapy at hospitals that receive them.
The three-phase study focuses on acute myocardial infarction (AMI) and congestive heart
failure (CHF) and involves 85 hospital corporations (consisting of 103 acute care hospitals)
in Ontario. As part of the study design, the hospitals were randomized into two groups:
Group A-Early feedback hospitals (44 hospital corporations/53 hospitals) and Group B-Delayed
feedback hospitals (41 hospital corporations/50 hospitals).
Phase I A retrospective chart review of hospitalizations from 1999/00 and 2000/01 was
conducted in the participating Ontario hospital corporations. Findings from Phase I were
documented in two reports:
- Report 1. Report Cards on Group A-Early Feedback Hospitals, released January 2004;
- Report 2. Report Cards on Group B-Delayed Feedback Hospitals, to be released September
2005.
In addition to demographic and treatment information, study data also focus on two sets of
quality indicators—one for AMI care and one for CHF care. Canadian Cardiovascular Outcomes
Research Team (CCORT) investigators, in conjunction with the Canadian Cardiovascular Society
(CCS), formed two expert panels to define Canadian AMI and CHF Quality Indicators. The
expert panels' membership included clinical leaders in cardiology, internal medicine, family
practice, nursing, pharmacy and epidemiology. The indicators are posted on the CCORT web
site (www.ccort.ca) and have been published in the Canadian Journal of Cardiology. The
study's Technical Advisory Committee reviewed all of the proposed AMI and CHF quality
indicators and recommended a final list of indicators for inclusion in the EFFECT report
cards.
Phase II Report Cards for Group A-Early Feedback Hospitals and Group B-Delayed Feedback
Hospitals based on a second phase of retrospective chart review of 2004/05 hospitalizations.
(Release in 2006/07)
Phase III Final Report—Impact Assessment: A comparison of results/improvement from Phase I
to Phase II. (Release in 2006/07)
Sources of Funding The EFFECT study is being funded by the Canadian Institutes of Health
Research (CHIR) Interdisciplinary Health Research Team (IHRT) Program and the Heart and
Stroke Foundation of Canada, with in kind support from the Institute for Clinical Evaluative
Sciences.
Principal Investigators The EFFECT study is being led by Dr. Jack V. Tu, MD, PhD, Senior
Scientist, ICES, Canada Research Chair, Health Services Research.
;
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04451967 -
Acute Myocardial Infarction Study in Northeastern China
|
||
Completed |
NCT05974397 -
Nationwide Trends in Incidence, Healthcare Utilization, and Mortality in Hospitalized Acute Myocardial Infarction Patients in Taiwan
|
||
Not yet recruiting |
NCT04072081 -
Drug-coated Balloon Versus Drug-eluting Stent in the Treatment of Coronary Artery Lesions in STEMI Patients in De Novo Coronary Lesions
|
N/A | |
Recruiting |
NCT03940443 -
Differences in Mortality and Morbidity in Patients Suffering a Time-critical Condition Between GEMS and HEMS
|
||
Recruiting |
NCT03707626 -
Collateral Circulation to LAD and Wellens Sign
|
||
Completed |
NCT02669810 -
EXCELLENT (EXpanded CELL ENdocardiac Transplantation)
|
Phase 2 | |
Not yet recruiting |
NCT04104048 -
Short Term Outcome of Primary Precutaneous Coronary Intervention in Ostial Versus Non Ostial Culprit Proximal Left Anterior Descending Artery Acute Myocardial Infraction
|
||
Active, not recruiting |
NCT02915107 -
The SORT OUT IX STEMI OCT Trial
|
N/A | |
Completed |
NCT02896543 -
The Relationship of Change of Dendritic Cells Fractalkine and P-selectin Patients With Acute Myocardial Infarction
|
N/A | |
Completed |
NCT02490969 -
Copeptin Registry (proCORE) Biomarkers in Cardiology (BIC)-19
|
N/A | |
Completed |
NCT02531165 -
Platelet Inhibition After Pre-hospital Ticagrelor Using Fentanyl Compared to Morphine in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
|
N/A | |
Withdrawn |
NCT01901471 -
Cyclosporine in Acute Myocardial Infarction Complicated by Cardiogenic Shock
|
Phase 2 | |
Completed |
NCT02312336 -
A Pilot Study of Transcoronary Myocardial Cooling
|
N/A | |
Recruiting |
NCT02071342 -
Study of ABSORB Stent in Acute Myocardial Infarction
|
N/A | |
Terminated |
NCT01972126 -
MAGNetic QRS-Fragmentation in Patients With Myocardial InfarcTion and Moderately RedUceD Ejection Fraction
|
N/A | |
Completed |
NCT02070913 -
COOL-AMI EU Case Series Clinical Study
|
||
Completed |
NCT01887080 -
Effects of Microcurrent in a Cardiovascular Rehabilitation Home-based Program
|
N/A | |
Withdrawn |
NCT01678339 -
Sicilian Administrative Data Base Study in Acute Coronary Syndrome Patients
|
N/A | |
Completed |
NCT01216995 -
Safety and Efficacy of Adipose Derived Regenerative Cells (ADRCs) Delivered Via the Intracoronary Route in the Treatment of Patients With ST-elevation Acute Myocardial Infarction (AMI)
|
Phase 2 | |
Completed |
NCT01673893 -
ClearWay Rx Readmission Registry
|